Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Core tablet for controlled release of gliclazide after oral administration

Core tablet for controlled release of gliclazide after oral administration

US Patent 6733782 · Granted May 11, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orodispersible pharmaceutical composition for oromucosal or sublingual administr2011
Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone2007
Solid thermoformable controlled-release pharmaceutical composition2001
Anti-graffiti paint composition2001
Pharmaceutical composition for the programmed release of dexfenfluramine1999
Matrix tablet allowing the prolonged release of the sodium salt of tianeptine af1999
Matrix tablet allowing the prolonged release of the sodium salt of tianeptine af1999